Company Filing History:
Years Active: 1996-1997
Title: Thomas Kr Amer: Innovator in Medicinal Chemistry
Introduction
Thomas Kr Amer is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, holding a total of 4 patents. His work primarily focuses on developing compounds that can be utilized in the treatment of various medical conditions.
Latest Patents
Among his latest patents are the sulphonylbenzyl-substituted imidazolylpropenoic acid derivatives. These compounds can be synthesized by reacting sulphonylbenzyl-substituted aldehydes with appropriate CH-acidic compounds, followed by dehydration. They are particularly valuable in the medical field for treating high blood pressure and atherosclerosis. Another significant patent involves substituted biphenylpyridones, which can be prepared by alkylating pyridones on the nitrogen. These biphenylpyridones serve as active substances in medicaments, especially in hypotensive and anti-atherosclerotic treatments.
Career Highlights
Thomas Kr Amer is currently associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His innovative work has positioned him as a key player in the development of new therapeutic agents.
Collaborations
Throughout his career, Thomas has collaborated with esteemed colleagues such as Matthias Müller-Gliemann and Martin Beuck. These partnerships have further enhanced his research and development efforts in medicinal chemistry.
Conclusion
Thomas Kr Amer's contributions to medicinal chemistry through his patents and collaborations highlight his commitment to advancing healthcare solutions. His work continues to impact the treatment of critical health issues, showcasing the importance of innovation in medicine.